Robotic kidney transplant from living donors
Part of Kidney & urinary, Women’s health & pregnancy clinical trials.
This trial studies the results of kidney transplants using robotic surgery from living donors. It may help patients receive kidneys with potentially less impact from surgery.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are getting a kidney from a living donor
- You will take the usual three immunosuppressive medicines after transplant
- You do not have an active infection
- You are not receiving another organ at the same time
- Neither you nor your donor has a history of cancer
- You do not have HIV
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether giving a special type of immune cells from your kidney donor (called ECP-DL cells) can help your body accept the new kidney without strong anti-rejection drugs. It is for people who are getting their first kidney transplant from a donor who is not a perfect genetic match.
This study looks at how genes affect long-term kidney transplant health. It aims to understand why some transplanted kidneys fail over time, and may help personalize care for transplant recipients.
This review looks at results for kidney donors and recipients who had kidney transplant surgery done either by hand-assisted or robotic methods. It aims to understand how these surgical approaches affect donor and recipient outcomes.
This study looks at how well kidney transplants work from both living and deceased donors. It may help doctors better understand long-term outcomes for people who get a new kidney.
This trial is testing a way to help your body accept a kidney transplant without needing lifelong anti-rejection drugs. It is for people getting a kidney from a living donor who is a relative and has a compatible blood type.
This Phase 2 trial studies a treatment using immune cells made from your living donor, given around the time of kidney transplant. It aims to improve transplant safety and outcomes by adjusting the immune response to the new kidney.
Hear when a new Kidney Transplant; Complications trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.